1620 Investment Advisors’s Eli Lilly LLY Stock Holding History

1620 Investment Advisors’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$186K	Buy	154 +1	+0.7%	+$1.02K	0.12%	188
2026 Q1	$141K	Sell	153 -5	-3%	-$5.07K	0.1%	192
2025 Q4	$171K	Sell	158 -23	-13%	-$22K	0.11%	175
2025 Q3	$138K	Sell	181 -15	-8%	-$11.2K	0.09%	187
2025 Q2	$153K	Sell	196 -33	-14%	-$25.6K	0.11%	176
2025 Q1	$189K	Sell	229 -12	-5%	-$9.98K	0.14%	151
2024 Q4	$186K	Sell	241 -7	-3%	-$5.8K	0.14%	159
2024 Q3	$219K	Buy	248 +11	+5%	+$9.89K	0.16%	147
2024 Q2	$215K	Buy	+237	New	+$190K	0.16%	147
2023 Q4	–	Sell	-393	Closed	-$211K	–	146
2023 Q3	$211K	Buy	+393	New	+$203K	0.24%	126

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ONB

Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

GIM

Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

1620 Investment Advisors's LLY Position: Q2 2026 in Review

1620 Investment Advisors increased its Eli Lilly (LLY) stake by 0.65% in Q2 2026, buying an estimated $1.02K and bringing the position to 154 shares worth $186K. The position accounts for 0.12% of the portfolio, ranked #188.

1620 Investment Advisors first reported a position in LLY in Q3 2023 and has held it in 10 quarters since. The position peaked at $219K in Q3 2024. 1,393 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

1620 Investment Advisors held 154 shares of Eli Lilly worth $186K as of Q2 2026.
1620 Investment Advisors bought 1 Eli Lilly share in Q2 2026, an estimated $1.02K.
Eli Lilly made up 0.12% of 1620 Investment Advisors's portfolio in Q2 2026, its #188 holding.
1620 Investment Advisors first reported a position in Eli Lilly in Q3 2023 and has held it in 10 quarters since.
1620 Investment Advisors's Eli Lilly position peaked at $219K in Q3 2024.
1,393 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on 1620 Investment Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.